KLK3 and prostate cancer: ELISA is commonly used to quantify protein biomarkers in a variety of biofluids, with ongoing improvements, such as Prostate-specific antigen (PSA) in the blood of suspected prostate cancer (PCa) patients as low as one hundred picograms per millilitre [9].